Durham-based BioCryst Pharmaceuticals Inc. plans to acquire Boston-based Astria Therapeutics Inc., adding the late-stage hereditary angioedema (HAE) treatment, navenibart, to its portfolio. The ...

There is no cure yet for OA of the knee. Short-term measures such as oral pain medications, physical therapy or steroid injections into the knee can provide short-term relief. There are only a handful ...

Hear directly from UNC faculty who’ve successfully navigated the commercialization process through startups, licensing, or industry partnerships. This engaging discussion will offer practical insights ...

The Quantra Hemostasis System is a cartridge-based viscoelastic testing system that uses a proprietary ultrasound technology ...

“We're all familiar with the cost-price squeeze in agriculture,” he said. “Our cost of production and output prices are ...

North Carolina is a leading life sciences hub with 840 companies employing 75,000 people. Statewide, life sciences companies of all sizes are developing treatments changing lives worldwide. These ...

Oxford-based Plantd has raised $22 million in venture capital to advance its production of carbon-negative building materials ...

Now North Carolina newcomer OXB, a UK-based CDMO in cell and gene therapy, announced Oct.7 that it has acquired the former ...